BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 31133374)

  • 1. High expression of meningioma 1 is correlated with reduced survival rates in colorectal cancer patients.
    Ho YJ; Liu FC; Chang J; Shi B; Yeh KT; Lin YM; Lu JW
    Acta Histochem; 2019 Jul; 121(5):628-637. PubMed ID: 31133374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
    Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
    Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low expression of RASSF10 is associated with poor survival in patients with colorectal cancer.
    Wang F; Li P; Feng Y; Hu YL; Liu YF; Guo YB; Jiang XL; Mao QS; Xue WJ
    Hum Pathol; 2017 Apr; 62():108-114. PubMed ID: 28041974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of p63 cytoplasmic expression in colorectal cancer. An immunohistochemical study.
    Albasri AM; Elkablawy MA; Ansari IA; Alhujaily AS; Khalil AA
    Saudi Med J; 2019 May; 40(5):432-439. PubMed ID: 31056618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of semaphorin 3D is associated with genesis and development in colorectal cancer.
    Wang Z; Ding M; Qian N; Song B; Yu J; Tang J; Wang J
    World J Surg Oncol; 2017 Mar; 15(1):67. PubMed ID: 28320475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large tumor suppressor 2 is a prognostic biomarker and correlated with immune infiltrates in colorectal cancer.
    Zhao C; Chen J; Liu Y; Ju S; Wang G; Wang X
    Bioengineered; 2021 Dec; 12(2):11648-11661. PubMed ID: 34699318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of chemokine receptor CXCR7 in colorectal carcinoma and its prognostic significance.
    Yang D; Dai T; Xue L; Liu X; Wu B; Geng J; Mao X; Wang R; Chen L; Chu X
    Int J Clin Exp Pathol; 2015; 8(10):13051-8. PubMed ID: 26722500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of RASSF10 correlates with poor prognosis in patients with colorectal cancer.
    Ma J; Zhang S; Hu Y; Li X; Yuan F; Sun D; Wang L; Zhang F; Chen G; Cui P
    Medicine (Baltimore); 2017 Oct; 96(42):e7011. PubMed ID: 29049167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of microRNA-152 in colorectal cancer and its relationship with prognosis].
    Wang Y; Yuan W; Ma X; Ma J
    Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):763-766. PubMed ID: 27784461
    [No Abstract]   [Full Text] [Related]  

  • 10. Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancer.
    Shen X; Bai Y; Luo B; Zhou X
    Biol Res; 2017 Oct; 50(1):32. PubMed ID: 28969673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ING4 suppresses tumor angiogenesis and functions as a prognostic marker in human colorectal cancer.
    Chen Y; Huang Y; Hou P; Zhang Z; Zhang Y; Wang W; Sun G; Xu L; Zhou J; Bai J; Zheng J
    Oncotarget; 2016 Nov; 7(48):79017-79031. PubMed ID: 27806345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the EP300, TP53 and BAX genes in colorectal cancer: Correlations with clinicopathological parameters and survival.
    Kowalczyk AE; Krazinski BE; Godlewski J; Kiewisz J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Kiezun J; Sulik M; Kmiec Z
    Oncol Rep; 2017 Jul; 38(1):201-210. PubMed ID: 28586030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression of the PLAGL1 (ZAC1/LOT1) gene in colorectal cancer: Correlations to the clinicopathological parameters.
    Kowalczyk AE; Krazinski BE; Godlewski J; Kiewisz J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Kiezun J; Wierzbicki PM; Bodek G; Sulik M; Kmiec Z
    Int J Oncol; 2015 Sep; 47(3):951-62. PubMed ID: 26134521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Aldehyde Dehydrogenase 1A1 (ALDH1A1) as a Prognostic Biomarker in Colorectal Cancer Using Immunohistochemistry.
    Yang W; Wang Y; Wang W; Chen Z; Bai G
    Med Sci Monit; 2018 May; 24():2864-2872. PubMed ID: 29748529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Lgr5, a marker of intestinal stem cells, in colorectal cancer and its clinicopathological significance.
    He S; Zhou H; Zhu X; Hu S; Fei M; Wan D; Gu W; Yang X; Shi D; Zhou J; Zhou J; Zhu Z; Wang L; Li D; Zhang Y
    Biomed Pharmacother; 2014 Jun; 68(5):507-13. PubMed ID: 24751002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of miR-552 acts as a potential predictor biomarker for poor prognosis of colorectal cancer.
    Wang N; Liu W
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):412-416. PubMed ID: 29424898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
    Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
    Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of ROR2 in cancer cell correlates with unfavorable prognosis in colorectal cancer.
    Mei H; Lian S; Zhang S; Wang W; Mao Q; Wang H
    Biochem Biophys Res Commun; 2014 Oct; 453(4):703-9. PubMed ID: 25301559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eukaryotic elongation factor-2 kinase expression is an independent prognostic factor in colorectal cancer.
    Ng TH; Sham KWY; Xie CM; Ng SSM; To KF; Tong JHM; Liu WYZ; Zhang L; Chan MTV; Wu WKK; Cheng CHK
    BMC Cancer; 2019 Jul; 19(1):649. PubMed ID: 31266475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.